JP2021505200A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505200A5 JP2021505200A5 JP2020550047A JP2020550047A JP2021505200A5 JP 2021505200 A5 JP2021505200 A5 JP 2021505200A5 JP 2020550047 A JP2020550047 A JP 2020550047A JP 2020550047 A JP2020550047 A JP 2020550047A JP 2021505200 A5 JP2021505200 A5 JP 2021505200A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- znf274
- targeting system
- snrpn
- dna targeting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762596397P | 2017-12-08 | 2017-12-08 | |
| US62/596,397 | 2017-12-08 | ||
| PCT/US2018/064517 WO2019113472A1 (en) | 2017-12-08 | 2018-12-07 | Compositions and methods for treating disorders of genomic imprinting |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021505200A JP2021505200A (ja) | 2021-02-18 |
| JP2021505200A5 true JP2021505200A5 (https=) | 2022-01-11 |
Family
ID=66750623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550047A Pending JP2021505200A (ja) | 2017-12-08 | 2018-12-07 | ゲノムインプリンティングの障害を治療するための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12018255B2 (https=) |
| EP (1) | EP3720508A4 (https=) |
| JP (1) | JP2021505200A (https=) |
| AU (1) | AU2018380422A1 (https=) |
| CA (1) | CA3084810A1 (https=) |
| WO (1) | WO2019113472A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3597741A1 (en) | 2012-04-27 | 2020-01-22 | Duke University | Genetic correction of mutated genes |
| US9828582B2 (en) | 2013-03-19 | 2017-11-28 | Duke University | Compositions and methods for the induction and tuning of gene expression |
| US10676726B2 (en) | 2015-02-09 | 2020-06-09 | Duke University | Compositions and methods for epigenome editing |
| EP4089175A1 (en) | 2015-10-13 | 2022-11-16 | Duke University | Genome engineering with type i crispr systems in eukaryotic cells |
| EA201891317A3 (ru) | 2015-11-30 | 2019-04-30 | Дьюк Юниверсити | Терапевтические мишени для коррекции гена дистрофина человека с помощью редактирования генов и способы их применения |
| US20190127713A1 (en) | 2016-04-13 | 2019-05-02 | Duke University | Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use |
| WO2018017754A1 (en) | 2016-07-19 | 2018-01-25 | Duke University | Therapeutic applications of cpf1-based genome editing |
| WO2019144061A1 (en) | 2018-01-19 | 2019-07-25 | Duke University | Genome engineering with crispr-cas systems in eukaryotes |
| CN111770758A (zh) * | 2018-02-27 | 2020-10-13 | 北卡罗来纳-查佩尔山大学 | 用于治疗Angelman综合征的方法和组合物 |
| WO2021067878A1 (en) * | 2019-10-02 | 2021-04-08 | Duke University | Epigenetic modulation of genomic targets to control expression of pws-associated genes |
| IL317874A (en) | 2022-06-24 | 2025-02-01 | Tune Therapeutics Inc | Compounds, systems and methods for reducing low density lipoproteins through targeted gene suppression |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| EP0646178A1 (en) | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
| US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| US20050244851A1 (en) * | 2004-01-13 | 2005-11-03 | Affymetrix, Inc. | Methods of analysis of alternative splicing in human |
| US20100099746A1 (en) * | 2006-12-18 | 2010-04-22 | Kyowa Hakko Kirin Co., Ltd. | Novel nucleic acid |
| GB0718542D0 (en) * | 2007-09-22 | 2007-10-31 | Univ Dundee | Targeted modulation of gene expression |
| US9920317B2 (en) * | 2010-11-12 | 2018-03-20 | The General Hospital Corporation | Polycomb-associated non-coding RNAs |
| EP3286318A2 (en) | 2015-04-22 | 2018-02-28 | Mina Therapeutics Limited | Sarna compositions and methods of use |
-
2018
- 2018-12-07 CA CA3084810A patent/CA3084810A1/en active Pending
- 2018-12-07 AU AU2018380422A patent/AU2018380422A1/en not_active Withdrawn
- 2018-12-07 US US16/770,877 patent/US12018255B2/en active Active
- 2018-12-07 JP JP2020550047A patent/JP2021505200A/ja active Pending
- 2018-12-07 EP EP18886571.1A patent/EP3720508A4/en not_active Withdrawn
- 2018-12-07 WO PCT/US2018/064517 patent/WO2019113472A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505200A5 (https=) | ||
| JP6929791B2 (ja) | エピゲノム編集のための組成物および方法 | |
| KR20200097751A (ko) | 근위축증 및 근긴장성 이영양증을 치료하는 조성물 및 방법 | |
| WO2019094791A3 (en) | Targeted crispr delivery platforms | |
| IL325248A (en) | Oligonucleotides for inducing paternal ube3a expression | |
| JP2018536689A5 (https=) | ||
| JP2017537611A5 (https=) | ||
| JP2019531763A5 (https=) | ||
| JP2018533954A5 (https=) | ||
| JP2016502858A5 (https=) | ||
| JP2018523668A5 (https=) | ||
| JP2020517653A5 (https=) | ||
| JP2015532097A5 (https=) | ||
| JP2010259439A5 (https=) | ||
| WO2000009525A3 (en) | Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments | |
| JP2017532961A5 (https=) | ||
| JP2019533472A5 (https=) | ||
| MX420940B (es) | Oligonucleótido bicatenario específico del gen de anfirregulina y composición para prevenir y tratar enfermedades relacionadas con la fibrosis y enfermedades respiratorias, que comprende el mismo. | |
| Újvári et al. | Histone N-terminal tails interfere with nucleosome traversal by RNA polymerase II | |
| JP2019517262A5 (https=) | ||
| EP1758998A4 (en) | OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF IN THE TREATMENT OF FIBROUS CONDITIONS AND OTHER DISEASES | |
| US20180296635A1 (en) | Protein Particles Comprising Disulfide Crosslinkers and Uses Related Thereto | |
| JP2020521491A5 (https=) | ||
| JP2011505798A5 (https=) | ||
| CN118043461A (zh) | 方法 |